Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1296Other hematologic neoplasm 892Breast 634Plasma cell 365Myeloid 259Sarcoma 210Dermatologic 193CNS 177Gastrointestinal 134Gynecologic 126Genitourinary 116Thoracic 101Classical hematology 93Other solid neoplasm 71Head & Neck 48Tumor-Agnostic 28Other neoplasm 13Endocrine 6NET 4Other 2

Conditions

Obesity 1Mucositis 1Leukemia 1Breast Neoplasms 1Body Weight 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cyclophosphamide × Other × Clear all
NCT01085617 2025-03-30

UKALL14

University College, London

Completed
OtherOther hematologic neoplasm

Leukemia, Mucositis

NCT01537029 2018-08-22

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

Texas Tech University Health Sciences Center

Phase 4 Completed
15 enrolled 6 charts
BreastOther

Body Weight, Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡